CancerICD-10: C44Most common cancer in the US with over 5 million cases treated annually

Skin Cancer

Also known as: Cutaneous malignancy

Skin cancer is the abnormal growth of skin cells, most commonly caused by excessive ultraviolet radiation from the sun or tanning beds. The three main types are basal cell carcinoma, squamous cell carcinoma, and melanoma, with melanoma being the most dangerous. Early detection through regular skin checks dramatically improves treatment outcomes.

Last updated November 10, 2026

Understanding Skin Cancer

Skin cancer is the uncontrolled growth of skin cells damaged, in most cases, by ultraviolet light, and it is by far the most common cancer in the United States: about 5.4 million basal and squamous cell carcinomas are treated in roughly 3.3 million Americans each year, more than all other cancers combined, and one in five Americans develops a skin cancer by age 70. Basal cell carcinoma (BCC) makes up about 80 percent of these and almost never spreads; cutaneous squamous cell carcinoma (SCC) makes up most of the rest, spreads in about 2 to 5 percent of cases, and causes an estimated 4,000 to 9,000 deaths a year. Melanoma, the pigment-cell cancer, is about 1 percent of skin cancers but most of the deaths, and has its own page. Rarer types include Merkel cell carcinoma, an aggressive tumor with about 3,000 cases a year, mostly in older adults. Risk rises with fair skin, cumulative sun, tanning-bed use, age and, above all, a suppressed immune system: organ-transplant recipients develop SCC at 65 to 100 times the general rate.

Ultraviolet B light fuses adjacent DNA bases into dimers, and when repair fails the result is a characteristic cytosine-to-thymine 'UV signature' mutation; the sun-exposed skin of a 60-year-old carries thousands of such mutations per cell. BCC and SCC take different routes. About 90 percent of BCCs have lost the PTCH1 brake on the Hedgehog growth pathway, and their risk tracks intermittent intense exposure and childhood sunburns, which is why they appear on the face and trunk of office workers. SCC reflects cumulative dose, arises on the most weathered skin (scalp, ears, lips, forearms, hands) and often grows out of actinic keratoses, the rough pink patches of sun damage that each carry a small chance of transformation, under 1 percent a year, though roughly 60 percent of SCCs begin in one. Immune surveillance normally removes mutant cells, which is why transplant drugs, chronic lymphocytic leukemia and HIV raise the risk and make SCC more aggressive. Both cancers grow slowly over months to years, and BCC, left alone, erodes locally into cartilage and bone rather than spreading.

The American Academy of Dermatology's 2018 guidelines for BCC and SCC start with a biopsy, because treatment depends on subtype and depth. Standard excision with a 4 mm margin clears about 95 percent of low-risk BCCs; Mohs micrographic surgery, which examines the entire margin in stages on the same day, achieves 5-year recurrence of about 1 percent for primary BCC and is reserved for the face, recurrent or aggressive tumors and immunosuppressed patients. Superficial BCCs and in-situ SCCs can be treated with curettage and electrodesiccation, imiquimod cream or photodynamic therapy, though in a 501-patient trial 5-year success was 98 percent for excision against 83 percent for imiquimod. Actinic keratoses respond best to 5-fluorouracil cream: in a 624-patient trial it kept 75 percent of treated fields clear at 12 months versus 54 percent for imiquimod. Rare advanced cases have drugs: hedgehog inhibitors for BCC and the PD-1 antibody cemiplimab for SCC, each helping about half of patients. After one keratinocyte cancer, about 40 percent of people develop another within 5 years, so skin checks every 6 to 12 months are part of treatment.

No supplement, cream or diet treats an existing skin cancer, and the trials that tested prevention have produced one modest winner and several losers. Nicotinamide cut new BCCs and SCCs by 23 percent over 12 months in the 386-patient ONTRAC trial, though a 2023 trial in 158 organ-transplant recipients found no significant benefit. Daily sunscreen reduced new SCCs by about 40 percent in the 1,621-person Nambour trial. On the losing side, selenium 200 mcg a day increased SCC by 25 percent in the 1,312-patient Nutritional Prevention of Cancer trial, beta-carotene did nothing in 1,805 people over 5 years, vitamin D did not reduce skin or other cancers in the 25,871-person VITAL trial, and oral vitamin E, green tea extract and curcumin have no human prevention data. High-dose oral retinol modestly reduced SCC in one trial, at a dose above the safe upper limit and with no effect on BCC. Black salve and other 'escharotic' pastes sold online to burn off skin cancers destroy skin unpredictably, leave tumor behind and have caused disfigurement; the FDA has warned against them.

The most common mistake is waiting for a spot to behave the way cancer is 'supposed' to: to hurt, grow fast or turn black. BCCs are usually pearly, pink or skin-colored and sit for months as a bump or a sore that heals and reopens; SCCs are scaly, crusted or warty bumps that may be tender. The useful rule is that any sore that has not healed in 4 weeks, any new growth in sun-damaged skin, or any patch that bleeds with light contact needs a dermatologist, and 'a pimple that won't go away' on the nose is the classic story of a BCC left for two years. The second mistake is thinking that because BCC rarely spreads it can be ignored or treated with a cream from the internet; it does not stop growing, and a 5 mm lesion is a simple procedure while a 3 cm one needs a flap repair. The third is stopping sun protection after treatment because the damage is done: the 40 percent five-year chance of a second cancer is the reason to start.

At a Glance

Common symptoms
New or changing mole or skin growth, A sore that does not heal, Pearly or waxy bump on the skin
Main treatments
Surgical excision of the cancerous tissue, Mohs micrographic surgery for precise removal, Cryotherapy for superficial lesions
Category
Cancer · Most common cancer in the US with over 5 million cases treated annually
See a doctor if
Any new, changing, or unusual skin growth

Symptoms

New or changing mole or skin growth
A sore that does not heal
Pearly or waxy bump on the skin
Flat, flesh-colored or brown scar-like lesion
Irregular borders, color, or shape in a mole
Itching, tenderness, or pain in a skin lesion
Bleeding or oozing from a skin spot
Changes in size, shape, or color of an existing mole

Causes

  • Cumulative ultraviolet radiation exposure from sunlight
  • Use of tanning beds and sunlamps
  • DNA damage in skin cells from UV radiation
  • Exposure to certain chemicals such as arsenic

Risk Factors

  • Fair skin with light hair and eyes
  • History of severe sunburns especially in childhood
  • Excessive sun exposure or tanning bed use
  • Family or personal history of skin cancer
  • Many moles or atypical moles
  • Weakened immune system

Diagnosis

  • Skin examination using the ABCDE criteria for moles
  • Dermoscopy for detailed lesion evaluation
  • Skin biopsy for histopathological examination
  • Sentinel lymph node biopsy for melanoma staging
  • Imaging studies for advanced-stage cancer

Treatment

  • Surgical excision of the cancerous tissue
  • Mohs micrographic surgery for precise removal
  • Cryotherapy for superficial lesions
  • Radiation therapy for non-surgical candidates
  • Immunotherapy and targeted therapy for advanced melanoma
  • Topical chemotherapy creams for superficial basal or squamous cell carcinoma

Natural remedies for skin cancer: what the evidence says

Ranked by the strength of human evidence for skin cancer specifically. These sit alongside medical care, not in place of it.

  1. Nicotinamide (vitamin B3)

    Moderate evidence

    Nicotinamide replenishes the cellular energy that UV-damaged skin cells need to repair DNA and blunts UV-induced immune suppression. In the phase 3 ONTRAC trial, 386 Australians who had already had at least two keratinocyte skin cancers took 500 mg twice daily or placebo for 12 months; new BCCs and SCCs fell by 23 percent and actinic keratoses by about 13 percent, with the benefit gone within 6 months of stopping. A 2023 trial of the same dose in 158 organ-transplant recipients, the highest-risk group, found no significant reduction, so the evidence is Moderate for immunocompetent people with heavy sun damage and a history of these cancers, and absent for melanoma.

    Studied dose
    Nicotinamide (niacinamide) 500 mg twice daily with food, taken continuously; nicotinic acid (niacin) is a different form that causes flushing and does not substitute.
    Cautions
    Well tolerated at this dose; much higher doses can raise liver enzymes and blood sugar. It is not a sunscreen substitute and does not treat an existing cancer; discuss it with your dermatologist or transplant team before starting.
  2. People told to avoid the sun after a skin cancer frequently become vitamin D deficient, and observational studies have linked low levels to more aggressive keratinocyte cancers, but the randomized evidence is clear that supplements do not prevent skin cancer: the VITAL trial gave 2,000 IU daily to 25,871 adults for a median of 5.3 years and found no reduction in cancer incidence, including skin cancers. The reason to supplement is bone and muscle health while you avoid UV, which is a far safer way to get vitamin D than sun or a tanning bed.

    Studied dose
    If 25-hydroxyvitamin D is below 20 ng/mL (50 nmol/L), 1,000 to 2,000 IU vitamin D3 daily, rechecked after 3 months; there is no evidence for higher doses in skin cancer.
    Cautions
    Doses above 4,000 IU daily without monitoring can raise calcium. Never use vitamin D as a justification for unprotected sun or tanning beds; a few minutes of incidental exposure plus diet and a supplement covers the need without the UV dose that caused the cancer.

What matters day to day

  • Make shade and clothing the first line when the UV index is 3 or higher, typically 10 a.m. to 4 p.m. from spring to autumn: a UPF 50 shirt blocks 98 percent of UV with no reapplication, and a hat with a 3-inch brim covers the nose, ears and neck, where most keratinocyte cancers occur.
  • Apply broad-spectrum SPF 30 or higher sunscreen at the tested amount, about 1 ounce (a shot glass) for the body and a teaspoon for the face and neck, and reapply every 2 hours outdoors: most people apply a quarter to half as much, which turns SPF 30 into SPF 5 to 10, and daily use reduced new SCCs by about 40 percent in the Nambour trial.
  • Never use a tanning bed: in a 2012 meta-analysis of 12 studies, ever-use raised SCC risk by 67 percent and BCC by 29 percent, with higher risk the younger the first use, and the International Agency for Research on Cancer classes tanning devices as a group 1 carcinogen alongside tobacco.
  • Protect the lips and the left side of the body: lip SCC spreads more readily than SCC elsewhere, so use an SPF 30 lip balm, and ordinary car side windows block UVB but let through most UVA, which is why skin cancers in US drivers cluster on the left face and arm; a UV-blocking window film or a sleeve fixes this.
  • If you are immunosuppressed, after a transplant or with CLL or HIV, have a full-skin dermatology examination every 6 to 12 months and treat actinic keratoses early: SCC in transplant recipients is both far more common and more likely to spread, and your transplant team can sometimes switch to an immunosuppressant (an mTOR inhibitor) that lowers skin cancer risk.
  • Stop smoking: smokers have about a 50 percent higher risk of cutaneous SCC in pooled studies, particularly on the lip, and smoking also slows healing after skin surgery and raises the chance of a wound complication after a flap or graft repair.

Prevention

  • Applying broad-spectrum SPF 30+ sunscreen daily
  • Wearing protective clothing and wide-brimmed hats
  • Avoiding sun exposure during peak hours of 10 AM to 4 PM
  • Avoiding tanning beds completely
  • Performing monthly skin self-examinations

When to See a Doctor

  • Any new, changing, or unusual skin growth
  • A mole that changes in size, shape, or color
  • A sore that does not heal within a few weeks
  • Any skin lesion that bleeds, itches, or is painful

Frequently Asked Questions

References

  1. Chen AC, Martin AJ, Choy B, et al.. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. New England Journal of Medicine (2015)
  2. Allen NC, Martin AJ, Snaidr VA, et al.. Nicotinamide for skin-cancer chemoprevention in transplant recipients. New England Journal of Medicine (2023)
  3. Green A, Williams G, Neale R, et al.. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet (1999)
  4. Duffield-Lillico AJ, Slate EH, Reid ME, et al.. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. Journal of the National Cancer Institute (2003)
  5. Kim JYS, Kozlow JH, Mittal B, et al.. Guidelines of care for the management of basal cell carcinoma. Journal of the American Academy of Dermatology (2018)
  6. Alam M, Armstrong A, Baum C, et al.. Guidelines of care for the management of cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology (2018)
  7. Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatology (2015)
  8. Bath-Hextall F, Ozolins M, Armstrong SJ, et al.. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. Lancet Oncology (2014)
  9. Jansen MHE, Kessels JPHM, Nelemans PJ, et al.. Randomized trial of four treatment approaches for actinic keratosis. New England Journal of Medicine (2019)
  10. MedlinePlus, National Library of Medicine. Skin Cancer (2024)View source

Related Conditions

Have questions about Skin Cancer?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.